These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Systemic ketamine attenuates nociceptive behaviors in a rat model of peripheral neuropathy. Qian J; Brown SD; Carlton SM Brain Res; 1996 Apr; 715(1-2):51-62. PubMed ID: 8739622 [TBL] [Abstract][Full Text] [Related]
48. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity. Becker A; Grecksch G Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753 [TBL] [Abstract][Full Text] [Related]
49. Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex. Sales AJ; Fogaça MV; Sartim AG; Pereira VS; Wegener G; Guimarães FS; Joca SRL Mol Neurobiol; 2019 Feb; 56(2):1070-1081. PubMed ID: 29869197 [TBL] [Abstract][Full Text] [Related]
51. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia. Becker A; Grecksch G; Zernig G; Ladstaetter E; Hiemke C; Schmitt U Psychopharmacology (Berl); 2009 Mar; 202(4):579-87. PubMed ID: 18810393 [TBL] [Abstract][Full Text] [Related]
52. CBD modulates DNA methylation in the prefrontal cortex and hippocampus of mice exposed to forced swim. Sales AJ; Guimarães FS; Joca SRL Behav Brain Res; 2020 Jun; 388():112627. PubMed ID: 32348868 [TBL] [Abstract][Full Text] [Related]
53. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034 [TBL] [Abstract][Full Text] [Related]
54. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics. Hollmann MW; Liu HT; Hoenemann CW; Liu WH; Durieux ME Anesth Analg; 2001 May; 92(5):1182-91. PubMed ID: 11323344 [TBL] [Abstract][Full Text] [Related]
55. Effects of Electroacupuncture on Expression of D1 Receptor (D1R), Phosphorylation of Extracellular-Regulated Protein Kinase 1/2 (p-ERK1/2), and c-Fos in the Insular Cortex of Ketamine-Addicted Rats. Wu F; Ding J; Li HB; Miao HC; Bao R; Yang S Med Sci Monit Basic Res; 2019 Jan; 25():26-32. PubMed ID: 30700692 [TBL] [Abstract][Full Text] [Related]
56. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Gao XM; Sakai K; Roberts RC; Conley RR; Dean B; Tamminga CA Am J Psychiatry; 2000 Jul; 157(7):1141-9. PubMed ID: 10873924 [TBL] [Abstract][Full Text] [Related]
57. Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week. Maia-de-Oliveira JP; Lobão-Soares B; Ramalho T; Gavioli EC; Soares VP; Teixeira L; Baker GB; Dursun SM; Hallak JE Schizophr Res; 2015 Mar; 162(1-3):211-5. PubMed ID: 25586741 [TBL] [Abstract][Full Text] [Related]
58. The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis. Hahn B Schizophr Bull; 2018 Jan; 44(1):46-53. PubMed ID: 29083450 [TBL] [Abstract][Full Text] [Related]
59. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Lemos JI; Resstel LB; Guimarães FS Behav Brain Res; 2010 Feb; 207(1):105-11. PubMed ID: 19800921 [TBL] [Abstract][Full Text] [Related]
60. Cannabidiol effects on prepulse inhibition in nonhuman primates. Saletti PG; Tomaz C Rev Neurosci; 2018 Dec; 30(1):95-105. PubMed ID: 29794254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]